{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T09:43:48Z","timestamp":1792489428356,"version":"4.5.0"},"reference-count":9,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004497","name":"Onderzoeksraad, KU Leuven","doi-asserted-by":"publisher","award":["C2M\/24\/057"],"award-info":[{"award-number":["C2M\/24\/057"]}],"id":[{"id":"10.13039\/501100004497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G038024N"],"award-info":[{"award-number":["G038024N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.kint.2026.04.044","type":"journal-article","created":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T15:18:08Z","timestamp":1784387888000},"page":"1084-1086","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Off-the-shelf CRISPR-engineered allogeneic human T-cell therapy for tolerance induction in transplantation"],"prefix":"10.1016","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2839-0154","authenticated-orcid":false,"given":"Tim","family":"Debyser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5625-0792","authenticated-orcid":false,"given":"Maarten","family":"Naesens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2026.04.044_bib1","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1146\/annurev-immunol-042718-041717","article-title":"Regulatory T cells and human disease","volume":"38","author":"Sakaguchi","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.kint.2026.04.044_bib2","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1681\/ASN.2014050480","article-title":"Central role of CD45RA\u2014Foxp3hi memory regulatory T cells in clinical kidney transplantation tolerance","volume":"26","author":"Braza","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2026.04.044_bib3","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124086","article-title":"Early expansion of donor-specific Tregs in tolerant kidney transplant recipients","volume":"3","author":"Savage","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.kint.2026.04.044_bib4","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(20)30167-7","article-title":"Regulatory cell therapy in kidney transplantation (the ONE study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1\/2A trials","volume":"395","author":"Sawitzki","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2026.04.044_bib5","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1097\/TP.0000000000005065","article-title":"Late treatment with autologous expanded regulatory T-cell therapy after alemtuzumab induction is safe and facilitates immunosuppression minimization in living donor renal transplantation","volume":"108","author":"Brook","year":"2024","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2026.04.044_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1626085","article-title":"Navigating the manufacturing, testing and regulatory complexities of regulatory T cells for adoptive cell therapy","volume":"16","author":"Pikor","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.kint.2026.04.044_bib7","doi-asserted-by":"crossref","first-page":"9090","DOI":"10.1038\/s41467-025-64945-3","article-title":"HLA matching or CRISPR editing of HLA class I\/II enables engraftment and effective function of allogeneic human regulatory T cell therapy in a humanized mouse transplantation model","volume":"16","author":"McCallion","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.kint.2026.04.044_bib8","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.kint.2021.11.029","article-title":"Allorecognition and the spectrum of kidney transplant rejection","volume":"101","author":"Callemeyn","year":"2022","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2026.04.044_bib9","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.ekir.2022.03.030","article-title":"Study design: human leukocyte antigen class I molecule A(\u2217)02-chimeric antigen receptor regulatory T cells in renal transplantation","volume":"7","author":"Schreeb","year":"2022","journal-title":"Kidney Int Rep"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253826005491?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253826005491?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T09:33:01Z","timestamp":1792488781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253826005491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":9,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0085253826005491"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2026.04.044","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Off-the-shelf CRISPR-engineered allogeneic human T-cell therapy for tolerance induction in transplantation","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2026.04.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Society of Nephrology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}